Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials - Concepedia

Concepedia

Publication | Open Access

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

DOI Full Paper Access

116

Citations

36

References

2022

Year

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki, Katherine Odem‐Davis, J. Young, Daniel Rosenbluth, Jennifer L. Taylor‐Cousar,

The Lancet Respiratory Medicine

MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis

References

	Year	Citations

Page 1